Neacşu E, Oniciu D, Simionescu L
C. I. Parhon Institute of Endocrinology, Bucharest, Romania.
Endocrinologie. 1990 Jan-Mar;28(1):25-31.
Testosterone-17-hemisuceinate (T-17-HS) by esterification with succinic anhydride technique and Testosterone-3-carboxy-methyl-oxyme (T-3-CMO) derivatives were synthesized. The T-protein (BSA) conjugates were prepared by the condensation with carbodiimide technique, for the T-17-HS derivative and by the mixed anhydride technique, for the T-3-CMO. Both the derivatives and the T-BSA conjugates were characterized by melting point, ultraviolet and infrared spectra, thin layer chromatography. The physico-chemical characteristics and the hapten-protein incorporation being convenient: 28 mol T/mol BSA for T-17-HS-BSA and 38 mol T/mol BSA for T-3-CMO-BSA, the T-carrier conjugates are adequate for their use as immunogens.
通过丁二酸酐技术进行酯化反应合成了睾酮-17-半琥珀酸酯(T-17-HS)以及睾酮-3-羧基-甲氧基甲酯(T-3-CMO)衍生物。采用碳二亚胺技术缩合制备了T-17-HS衍生物的T-蛋白(牛血清白蛋白,BSA)缀合物,采用混合酸酐技术制备了T-3-CMO的T-蛋白缀合物。通过熔点、紫外光谱、红外光谱和薄层色谱对衍生物和T-BSA缀合物进行了表征。物理化学特性以及半抗原-蛋白质结合情况较为适宜:T-17-HS-BSA为28摩尔T/摩尔BSA,T-3-CMO-BSA为38摩尔T/摩尔BSA,T-载体缀合物适合用作免疫原。